RYR2 and Alzheimer disease: In particular, RyR2 undergoes post-translational modifications (PKA-dependent phosphorylation, oxidation, nitrosylation) that destabilize its macromolecular complex with FKBP1b and lead to abnormal Ca2+ signaling in brains of AD patients [255].